Glonghui, April 24 | Puri Ophthalmology (301239.SZ) once fell by more than 11%. The low was 45.23 yuan, a new low since listing, and its total market capitalization fell below 7 billion yuan. According to news, the company's main revenue for the first quarter was 676 million yuan, up 4.01% year on year; net profit to mother was 16.924,900 yuan, down 89.58% year on year. The company's net profit returned to mother last year was 268 million yuan, an increase of 1202.56% over the previous year. It can be seen from this that the company's performance in the first quarter of this year was clearly under pressure.
A股异动丨Q1业绩承压,普瑞眼科一度跌超11%创新低
A-share changes丨Q1 performance was under pressure, and Puri Ophthalmology once fell more than 11% to a record low
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.